logo
  

Takeda Reaches Agreement With JCR Pharma To Commercialize JR-141 Outside Of U.S.

Takeda Pharmaceutical Company Limited (TKPHF.PK,TAK) and JCR Pharmaceuticals Co., Ltd. have entered a collaboration and license agreement to commercialize JR-141, an investigational, next-generation recombinant fusion protein of an antibody against the human transferrin receptor and iduronate-2-sulfatase enzyme for the treatment of Hunter syndrome. Under the agreement, Takeda will exclusively commercialize JR-141 outside of the United States, including Canada, Europe, and other regions (excluding Japan and certain other Asia-Pacific countries).

JCR will receive an upfront payment for the ex-U.S. license, and is eligible to receive additional development and commercial milestones as well as tiered royalties on potential sales.

Takeda also received an option under a separate option agreement, which allows it to acquire an exclusive license to commercialize JR-141 in the U.S. upon completion of the phase 3 program.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Lily's Sweets is recalling 18,855 cases of 7-ounce Peppermint Flavor Baking Chips citing the presence of undeclared soy lecithin, a known allergen, the U.S. Food and Drug Administration said. The product was a limited holiday seasonal offering available exclusively at Walmart stores in the United States. Cryptocurrency Dogecoin's price jumped over 15% on Friday, but later lost some of the gains, after Tesla Inc. (TSLA) CEO Elon Musk announced that the luxury car maker will start accepting the meme cryptocurrency as payment for its merchandise. "Tesla merch buyable with Dogecoin," Musk tweeted on Friday. Dogecoin... US investment bank JPMorgan Chase & Co. reported Friday a profit for the fourth quarter that declined 14 percent from last year, hurt primarily by higher noninterest expense and lower credit reserve releases. Both adjusted earnings per share and revenues for the quarter topped analysts' expectations.
RELATED NEWS
Follow RTT